Serologicals Corporation (SERO) Release: Upstate Introduces Pathway Profiler Service; Offers Faster, More Complete View Of Cellular Response; Helps To Compress Drug Discovery Time
10/19/2005 5:12:32 PM
ATLANTA--(BUSINESS WIRE)--Jan. 24, 2005--Upstate Group, Inc., a Serologicals (NASDAQ: SERO) company announced today the introduction of PathwayProfiler(TM), a new service that measures cell-based signaling cascades (cell communication pathways) and provides drug development companies with a unique insight into their therapy and its efficacy in the cell. PathwayProfiler(TM) is the only service of its kind currently available.
comments powered by